Observation of Blood Lipid Outcomes in Lipid Clinic

Observation of Blood Lipid Outcomes in Patients Who Receive Treatment in Lipid Clinic of Taipei MacKay Memorial Hospital

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04220164

Enrollment

500

Registered

2020-01-07

Start date

2020-01-03

Completion date

2025-12-31

Last updated

2020-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemias

Brief summary

Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.

Detailed description

Hyperlipidemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD), and therefore it is beneficial to prevent the risk of ASCVD by controlling the prevalence of hyperlipidemia. According to CEPHEUS Pan-Asia survey, the rate of LDL goal attainment in hyperlipidemic patients of Taiwan was suboptimal, especially in high-risk patients. 2017 Taiwan lipid guideline for high-risk patients has been published and clearly defined the treatment goal of blood LDL-C for high-risk patients. Besides, Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.

Interventions

OTHEREducation and inform the optimal threshold of LDL-C levels

Physicians educate patients and provide a clear information about optimal LDL-C value according to individual patient's condition according to current guidelines

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* ≥20 years-old * Abnormal lipid profiles according to 2017 Taiwan Lipid Guideline for High-risk Patients

Exclusion criteria

* Reject to participate in this study * Pregnant women * Prisoner * Illiteracy * HIV patients * Individuals who are mentally retarded, homeless, and handicapped

Design outcomes

Primary

Measure	Time frame	Description
Lipid profile	12 month	check serum level of LDL-C

Countries

Taiwan

Contacts

Primary ContactTing-Yun Lu

tingyunlu@gmail.com886-2-25433535

Backup ContactChao-Feng Lin, PhD

thcpci@gmail.com886-2-25433535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026